Loss of lifetime improved for patients with complications including stroke, HF and heart attack after a new atrial ...

The Metal Industries Research and Development Centre (MIRDC) has upheld Taiwan's global reputation for technological ...

Zanubrutinib plus venetoclax elicited durable responses in patients with treatment-naïve CLL or SLL and high-risk genetic features.

The following is a summary of “Ischemic outcomes after left atrial appendage closure following intracerebral hemorrhage: a ...